Final Exam - Engg 404 2022

Republic of the Philippines
BATANGAS STATE UNIVERSITY

The National Engineering University
Alangilan Campus
Golden Country Homes, Alangilan, Batangas City, Batangas, Philippines 4200
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
E-mail Address: ceafa@g.batstate-u.edu.ph | Website Address: http://www.batstate-u.edu.ph
College of Engineering, Architecture and Fine Arts

BACHELOR OF SCIENCE IN CHEMICAL
ENGINEERINGFINAL EXAMINATION
Second Semester, AY 2021-2022

Course Code
Course Title
Section
Date
Time
SR-Code 20-04624
Name of Student Mentoy Jan Jericho C.
Instructions to Students
1. Choose E if there are more than one correct option or

ILOs Questions Points
nocorrect answer at all from the given options.
2. Avoid rounding off during computations but only on
1 II. 1 – 10 10
finalanswers, up to four (4) decimal places, unless
specified.
4 II. 1 – 5 25
3. Upload your solutions and name it as <Section-Name-
Finals> (e.g., ChE-2201-de Guzman, Monroe-Finals) 5 III. 1- 20 50
NO. SECTIONS POINT
S
1. Concept Check (MC) 10
2. Application Check (MC) 25
3. Problem Solving 50
TOTAL POINTS 85
Leading Innovations, Transforming Lives

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221

I. Concept Check. (Mapped to ILO 1)
Specific Direction: Select the correct answer(s) for each item. If NONE or MORE THAN ONE of the choices is the
correct answer, choose E. (1 pt. each)
1. Which of these cannot be considered a non-compensatory attribute when buying a phone? E.

A. Cost B. Specifications C. Warranty D. Cannot decide
2. If there are three possible outcomes under the same decision node, then
A. the probability of each outcome occurring is 1/3.
B. the probability of one outcome occurring cannot exceed (or be less than) 1/3.
C. the chances of each outcome occurring vary depending on the problem.
D. its expected value will always be equal to 1.
3. If dominance check is used to conclude a decision from four alternatives,

A. then all attributes do not allow trade-offs.
B. then there shall be an alternative or option that will always be selected.
C. then there shall be (4)(2) comparison check by pairing.
D. then it is not allowed for the individual to provide his/her own preference on an attribute with nominal scale.
4. A decision tree analysis

A. has decision and outcome nodes.
B. can be used only in decisions admitting certainty.
C. does not consider attributes during solution.
D. shall always result to distinct expected values.
5. Decision reversal during sensitivity analysis

A. requires only a single parameter to be modified.
B. happens when the measure of equivalent worth becomes 0 after modifying a parameter.
C. is achieved when the equivalent worth becomes the negative of its original value.
D. can have multiple cases of occurrence depending on the parameter.
6. What can describe or exemplify a compensatory model?

A. A model that allows trade-offs of attribute.
B. When choosing a job, the health insurance compensates the lack of meal allowance.
C. There is no quantitative scale that separates two attributes.
D. The inferiority of one attribute against the other doesn’t mean removal from the choices immediately.
7. During sensitivity analysis, PW becomes 0 for an increased MARR and decreased number of economic life.
Which of these can be concluded? Note that PW is positive on the given initial condition.
A. The project is sensitive to MARR and economic life.
B. Increasing the number of years for its economic life must be done to avoid decision reversal.
C. MARR must be fixed to avoid decision reversal.
D. MARR and economic life must be fixed to avoid decision reversal.
8. What is/are the difference/similarities between lexicography and average weighting technique?
A. Significance of the attribute is more important in lexicography.
B. Attributes do not compensate for lexicography as compared with the other.
C. Lexicography is necessary to start average weighting technique, while average weighting technique is not
necessary to start lexicography.

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
D. Lexicography considers only one attribute, while the latter doesn’t.
9. In disjunctive resolution,
A. if an alternative never outperforms other alternative in all attributes, then it is likely to be
eliminated.
B. any alternative with all attributes falling within the range set by satisficing can still be eliminated.
C. an alternative with one of its attributes falling below the lowest value of the range set by satisficing shall
beeliminated.
D. alternatives eliminated by this method shall also be the same as those eliminated by satisficing.
10. If a decision is impossible to be made using one decision model, E.

A. a decision shall not be made.
B. one can try combining more than one models.
C. one must break the tie and simply choose randomly from the best options under tied bracket.
D. then there was an error in using that decision model.

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
II. Recommend the Best Project (Mapped to ILO 4)

Specific Direction: Given per number are three options for using the capital (or other parameters) of a certain project.
Pick out the best one. (5 pts. each). All values are given in Philippine peso.
1. Project A: Capital: 20,000,000. Annual Benefits: 200,000. Annual Expenses: 85,000. N = 3, i =3.7%
Project B: Capital: 30,000,000. Annual Benefits: 100,000. Annual Expenses: 65,000. N = 4, i =5.7%
Project C: Capital: 25,000,000. Annual Benefits: 150,000. Annual Expenses: 75,000. N = 5, i= 4.7%
TP(A) = -20,000,000 + (200000-85000)(1-(1+0.037)-3) = -Php 19,679.038.71

0.037
TP(B) =-30,000,000 + (100000-65000)(1-(1+0.057)-4) = -Php 29,887,883.51
0.057
TP(C) = -25,000,000 + (150000-75000)(1-(1+0.047)-5) = -Php 24,672,578.70
0.047
Correct Answer: Project A
2. Project A: B/C = 1.45. Total Annual Cost: 200,000. ∆(B/C) from reference = 0. Project A is the last one.
Project B: B/C = 1.78. Total Annual Cost: 300,000. ∆(B/C) from reference = 0. Project B is the last one.
Project C: B/C = 1.79. Total Annual Cost: 250,000. ∆(B/C) from reference = 0. Project C is the last one.
Correct Answer: Project C ; higher B/C Ratio
3. Project A: Additive weight:0.75

Project B: Additive weight:0.89
Project C: Additive weight:0.30
Correct Answer: Project B ; higher additive weight
4. The costs of the possible alternatives under one junction/node are: C1 = 20,000; C2 = 30,000; C3 =
45,000.The probability of each cost appearing based on the different scenarios are:
Project A: p(C1) =0.40; p(C2)= 0.35
Project B: p(C2) = 0.20; p(C3)= 0.25
Project C: p(C1)= p(C2) = p(C3)
TC(A)=20000(0.4) + 30000(0.35) + 45000(0.25) =Php 29750.00

TC(B) = 20000(0.2) + 30000(0.25) + 45000(0.55) = Php 36250.00
TC[C] = 20000(0.3333) + 30000(0.3333) + 45000(0.3333) = Php 31666.666…
Correct Answer: Project A
5. According to an individual, his preference of selecting a leader is based on three major factors in decreasing
order: Moral Values > Experience > Knowledge. The weights of the factors are 0.43, 0.31, and 0.26, respectively.
The performance values are written for each leader arranged as moral values – experience – knowledge:
Leader A: 1 – 0.5 – 0
Leader B: 0 – 0.25 – 1
Leader C: 0.5 – 0.5 – 0.5

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
LD(A)=1(0.43) + 0.5(0.31) + 0(0.26) = 0.585

LD(B) = 0(0.43) + 0.25(0.31) + 1(0.26) = 0.3375
LC[C] = 0.5(0.43) + 0.5(0.31) + 0.5(0.26) = 0.5
Correct Answer: Leader A
III. Problem Solving (Mapped to ILO 5)

Specific Direction: Solve each problem completely.
1. (2 pts.) Under a decision alternative, three outcomes O1 to O3 are possible. Suppose that at O1, PW = P250;
at O2, PW = P300; and at O3, PW = 0. What is the expected value if the combined probability of O2 and O3
is twice that of O1, and that O2 has a probability that is 30% of that of O3’s? (Write your final answer like
P200 using “P” as the peso sign.)
SOLUTION:
 PW:
O1 = 250
O2= 300
O3 = 0
 Let : P1 = x ; P2 =y ; P3 =z
 Equations
Eq 1: y+z = 2x
Eq 2:y=0.3z
Eq 3: x+y+z=1
 Compute P1
y+z = 2x
x+y+z=1
x+2x=1
3x=1
P1 = 1/3
 Compute P3
y+z = 2x ; y=0.3z ; x=1/3
0.3z + z = 2/3
1.3z = 2/3
P3 = 20/39
 Compute P2
y=0.3z ; z= 20/39
y=0.3(20/39)
P2=2/13
E(O)= O1(P1) + O2(P2) + O3(P3)

= P250(1/3) + P2300(2/13) + 0(20/39)
E(O)=P129.4872
(2 pts. each) For 2 – 6, refer to the decision tree below given the probabilities and respective equivalent worth (PW):

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
2. Find the value of A
E(D41)= P2700
E(D42)= -200(0.18)+2200(0.82)=P1768
E(D4)=A= P2700
A=P2700
3. Find the value of B.
B=2500(0.35)+1500(1-0.35)
B=2500(0.35)+1500(0.65)
B=P1850
B=P1850
4. Find the value of the present worth of C.
1250=1700(0.75)+C(0.25)
C= (1250-(1700*0.75))/0.25
C=-P100
C=-P100
5. What is the decision value at D2?

ED5=ED2=D2
D2=2100(0.4)+1000(0.6)
D2=P1440
D2=P1440
6. Find the decision value at D1.
 E(D31)=B
E(D31)=P1850
 E(D32)=500(0.32)+0(0.07)+3500(0.61)
E(D32)=P2295
 E(D33)=1250
D3=2295; P3=0.29; D2=1440; P2=0.71
 E(D11)=D2P2 + D3P3
D3=2295; P3=0.29; D2=1440; P2=0.71
E(D11)=1440(0.71)+2295(0.29)
E(D11)=1687.95
 E(D12)=A
E(D12)=2700
E(D12) > E(D11)
D1 = 2700
Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
For 7-9, refer to the problem below:

A ChE company plans to acquire a new equipment at a cost of P150,000 to increase their efficiency. The MARR =
10%. Based on analysis, AOC will amount to P31,000 while their annual revenue will amount to P50,000. The salvage
value will be P3,000 at the end of 15 years of economic life, and will be depreciated by P200 as the years increase
from 15-year period
7. Which of these conditions will indicate a decision reversal? (2 pts.)

A. Increase the MARR by 5.2172%.
B. Decrease the MARR to 9.4434%.
C. Increase the economic life by one more year.
D. Simultaneously increase the MARR by 1% while decreasing the economic life by 1 year.
SOLUTION
GIVEN
C=150,000
AOC= 31,000
AR=50,000
MV/SV=3,000
MARR=10 %
n=15 ; dk+15 =200
Initial
PW= -150,000 + 19000(1-(1+0.1)-15) + 3,000(1+0.1)-15 = -P4766.313232

0.1
PW(A)= -150,000 + 19000(1-(1+0.152172)-15) + 3,000(1+0.152172)-15 = -P39699.12384

0.152172
PW(B) = -150,000 + 19000(1-(1+0. 0.094434)-15) + 3,000(1+ 0.094434)-15 = P0.2252427161
0.094434
PW[C] = -150,000 + 19000(1-(1+0.1)-16) + 3,000(1+0.1)-16-200 = -P896.6483928
0.1
PW(D) =-150,000 + 19000(1-(1+0.11)-14) + 3,000(1+0.11)-14 = -P16648.57617
0.11
Since Condition B is the only condition that results in a positive value, Condition B is the only one who can cause a decision
revival.
Final Answer:B
8. On the perspective of the ChE company at the present time, is it economical to invest on the said equipment?
(1 pt.)
A. No. B. Yes. C. Maybe. D. Depends on the current situation.
PW= -150,000 + 19000(1-(1+0.1)-15) + 3,000(1+0.1)-15 = -P4766.313232

0.1
Final Answer: B, its not economical
9. What can be concluded with the sensitivity analysis if the MARR ranges from 9% to 11% and economic life
ranges from 12 to 15 years? (2 pts.)

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221

A. The acquisition of this equipment is both sensitive to changes in MARR and economic life relative to decision
reversal.
B. The acquisition of this equipment is only sensitive to changes in MARR relative to decision reversal.
C. The acquisition of this equipment is only sensitive to changes in the economic life relative to decision
reversal.
D. Neither the MARR nor the economic life causes sensitivity to decision reversal of the acquisition of the
equipment.
As MARR decreases from its initial value, PW increases value as it becomes more positive. Contrarily, when MARR
approaches the initial value, PW decreases as it becomes more negative.However, there’s no significant change in the sign
of PW when economic life is decrease or increase. However, there is still a difference in value. PW is sensitive to MARR.
Final Answer: B
For 10-15, refer to the problem below. (3 pts. each)

A non-compensatory model must be done to select the best vaccine available today to fight the COVID-19 and to
control its spread. Supposed that the government of the Philippines will be completely replaced with more
competent governance, and you will sit for the position of Department of Health, conduct the analysis and
recommend the best vaccine. So far, here are the data outsourced from different credible sites:
Attributes Pfizer Moderna AstraZeneca Sinovac Novava

x
Cost P2,379 P3,904 P610 P3,629.50 P366
Authorized ≥ 18 years
≥ 16 years ≥ 18 years old ≥ 18 years old 18-59 years old
Groups old
old
Efficacy (at full
94% 95% 62% 78% 89.7%
dose)
Storage
-70°C -20°C 7°C 7°C -7°C
Requirement
Shelf-life after
5 days 30 days 180 days 180 days 180 days
Thawed
Impact to
Fair Fair N/A N/A Good
COVID-variant
FDA-Emergency
Use Granted Granted Granted N/A N/A
Authorization
Protein
Delivery Method mRNA mRNA Viral Vector Viral Vector
Subunit
lYou are willing to pay at most P3,000 for the vaccination and having taken courses under epidemiology, hereare
some points that you have set:
1. Under the delivery method: mRNA > Protein Subunit > Viral Vector.
2. A longer shelf-life is better for efficient containment.
3. In terms of significance: Efficacy > FDA-EUA > Impact to Covid Variant > Shelf-life > Cost > Storage Requirement
> Authorized Groups > Delivery Method.
Some of the important factors are:
a. The age limit of the population is 100 years old. It is in ratio scale.
b. If data is not available, it is considered poor or 1 (in ordinal to ratio scale).
c. Percentages can be directly converted as ratings.

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
Attributes Pfizer Moderna AstraZeneca Sinovac Novavax

Cost P2,379 P3,904 P610 P3,629.50 P366
Authorized ≥ 18 years
≥ 16 years ≥ 18 years old ≥ 18 years old 18-59 years old
Groups old
old
Efficacy (at full
94% 95% 62% 78% 89.7%
dose)
Storage
-70°C -20°C 7°C 7°C -7°C
Requirement
Shelf-life after
Thawed
Impact to
COVID-variant
FDA-Emergency
Use Granted Granted Granted N/A N/A
Authorization
Protein
Delivery Method mRNA mRNA Viral Vector Viral Vector
Subunit
BEST VALUE, WORST VALUE
 DOMINANCE CHECK
Pfizer(P)
Moderna(M)
Astrazeneca(A)
Sinovac(S)
Novavax(N)
P vs M P vs A P vs S P vs N M vs A M vs S M vs N A vs S A vs N S vs N
Cost Better Worse Better Worse Worse Worse Worse Better Worse Worse
Authorized Better Better Better Better - Better - Better - Worse
Groups
Efficacy (at Worse Better Better Better Better Better Better Worse Worse Worse
fulldose)
Storage Worse Worse Worse Worse Worse Worse Worse - Better Better
Requirement
Shelf-life Worse Worse Worse Worse Worse Worse Worse - - -
after
Thawed
Impact to - Better Better Worse Better Better Worse - Worse Worse
COVID-
variant
FDA-Emergency - Better Better Better - Better Better Better Better -
Use
Authorization
Delivery Method - Better Better Better Better Better Better - Worse Worse
10. Under dominance check, which vaccine will be selected among the alternative? (3 pts.)
Under dominance check, none of the vaccines can be selected.
11. Considering your preference for delivery method as either Protein Subunit or mRNA, and the vaccine being

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
FDA-EU Authorized, which shall be selected among the alternatives by satisficing? Take note that for the other
attributes, the values under each attribute are within your set range. (3 pts.)
Through satisficing, the Pfizer Vaccine satisfy the parameters/conditions stated.
12. Using disjunctive resolution, how many vaccines shall be eliminated?
Through disjunctive resolution, none of the vaccines shall be eliminated.
13. If lexicography is applied considering the given significance, which vaccine will be selected?
Considering the efficacy as the most significant, arrange the vaccines based from efficacy
Efficacy: Moderna>Pfizer>Novavax>Sinovac>AstraZeneca
The Moderna Vaccine will be selected
14. If lexicography is applied considering FDA-EUA > Impact to Covid Variant > Cost > Efficacy > Shelf-life > Storage
Requirement > Authorized Groups > Delivery Method, which vaccine will be selected?
Arrange the vaccines from the given standard
 FDA-EUA:
Pfizer=Moderna=AstraZeneca>Sinovac=Novavax
 Impact to COVID Variant:
Novavax>Pfizer=Moderna>AstraZeneca=Sinovac
 Cost:
Novavax>AstraZeneca>Pfizer>Sinovac>Moderna
Based from the given standards, the Pfizer vaccine will be selected
15. Is it possible to select the best vaccine if dominance check is used, followed by satisficing in number 11?
A. Yes.
B. No.
C. Maybe.
D. Insufficient data.
Performing the dominance check followed by satisficting would not allow to select the best vaccine.
Final Answer: B
For 16-20, refer to the same problem as before assuming that all attributes are compensatory. Also, in the ordinal
ranking, the lowest value (1) goes to the least significant attribute. (3 pts. each)
Attributes Pfizer Moderna AstraZeneca Sinovac Novava

x
Cost P2,379 P3,904 P610 P3,629.50 P366
Authorize ≥ 18 years
≥ 16 years old ≥ 18 years old ≥ 18 years old 18-59 years old
dGroups old
Efficacy (at
94% 95% 62% 78% 89.7%
fulldose)
Storage
-70°C -20°C 7°C 7°C -7°C
Requiremen
t

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
Shelf-life
after
Thawed
Impact to
COVID-
variant
FDA-
EmergencyUse Granted Granted Granted N/A N/A
Authorization
Protein
Delivery mRNA mRNA Viral Vector Viral Vector
Subunit
Method
You are only willing to pay at most P3,000 for the vaccination and having taken courses under epidemiology, here
are some points that you have set:
1. Under the delivery method: mRNA > Protein Subunit > Viral Vector.
2. A longer shelf-life is better for efficient containment.
3. In terms of significance: Efficacy > FDA-EUA > Impact to Covid Variant > Shelf-life > Cost > Storage Requirement
> Authorized Groups > Delivery Method.
Some of the important factors are:
a. The age limit of the population is 100 years old. It is in ratio scale.
b. If data is not available, it is considered poor or 1 (in ordinal to ratio scale).
c. Percentages can be directly converted as ratings.
Order(Most To
Attributes Weight
Least)
8 Efficacy 0.22222222
7 FDA-EUA 0.194444444
6 Impact to Covid Variant 0.166666667
5 Shelf Life After Thawed 0.138888889
4 Cost 0.111111111
3 Storage Requirement 0.083333333
2 Authorized Groups 0.055555556
1 Delivery Method 0.027777778
36
Vaccine
Pfizer 0.94 0.9697
Moderna 0.95 1
Efficacy AstraZeneca 0.62 X-0.62 0
Sinovac 0.78 0.33 0.4849
Novavax 0.897 0.8394
Pfizer 2 1
Moderna 2 X-1 1
FDA-EUA AstraZeneca 2 1 1
Sinovac 1 0
Novavax 1 0
Pfizer 2 0.5
Impact to Moderna 2 X-1 0.5
COVID variant AstraZeneca 1 2 0
Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
Sinovac 1 0
Novavax 3 1
Pfizer 5 0
Moderna 30 X-5 0.1429
Shell Life AstraZeneca 180 175 1
After Thawed Sinovac 180 1
Novavax 180 1
Pfizer 2379 0.4310
Moderna 3904 3904-X 0
Cost(P) AstraZeneca 610 3538 0.9310
Sinovac 3629.5 0.0776
Novavax 366 1
Pfizer -70 0
Moderna -20 X+70 0.6494
Storage AstraZeneca 7 77 1
Requirement Sinovac 7 1
Novavax -7 0.8182
Pfizer 0.85 1
Moderna 0.83 X-0.42 0.9535
Authorized AstraZeneca 0.83 0.43 0.9535
Groups Sinovac 0.42 0
Novavax 0.83 0.9535
Pfizer 3 1
Moderna 3 X-1 1
Delivery Method AstraZeneca 1 2 0
Sinovac 1 0
Novavax 2 0.5
Attrib. Weights Pfizer Moderna AstraZeneca Sinovac Novavax

P WV P WV P WV P WV P WV
Efficacy 0.2222 0.9697 0.2155 1 0.2222 0 0 0.4849 0.1077 0.8394 0.1865
FDA- 0.1944 1 0.1944 1 0.1944 1 0.1944 0 0 0 0
EUA
Impact to 0.1667 0.5 0.0833 0.5 0.0833 0 0 0 0 1 0.1667
COVID
Variant
Shelf Life 0.1389 0 0 0.1429 0.0198 1 0.1389 1 0.1389 1 0.1389
after
Thawed
Cost 0.1111 0.4310 0.0479 0 0 0.9310 0.1034 0.0776 0.0086 1 0.1111
Storage 0.0833 0 0 0.6494 0.0541 1 0.0833 1 0.0833 0.8182 0.0682
Req.
Authorize 0.0556 1 0.0556 0.9535 0.0530 0.9535 0.0530 0 0 0.9535 0.0530
d Groups
Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
Delivery 0.0278 1 0.0278 1 0.0278 0 0 0 0 0.5 0.0139

Method
SUM 0.624 0.654 0.573 0.338 0.738
5 7 5 3
16. What is the weight % of the Impact to Covid Variant attribute? (Round to one decimal place.)
The weight % of the Impact to Covid Variant attribute is 16.7%
17. What is the total average weighted score of Pfizer vaccine? (Round to four decimal place.)
The total average weighted score of Pfizer vaccine is 0.6245
18. Which is the worst option based on total average weighted score?
The worst option based on total average weighted score is the Sinovac (0.3385)
19. What is the weight value of Sinovac’s efficacy? (Round to four decimal place.)
The weight value of Sinovac’s efficacy is 0.1077
20. What is the total average weighted score of the best vaccine based on compensatory analysis? (Round to four
decimal place.)
Novavax is the best vaccine based on compensatory analysis. It has a total average weighted score of
0.7383

Alangilan Campus
Tel No. (+63 43) 425-0139 loc. 2121 / 2221
-End of Examination-
Prepared by:
Engr. Monroe H. de Guzman

Lecturer, ENGG 404
Noted by:
Engr. Mary Rose F. Persincula

Department Head, ChE – FE
Approved by:
Dr. Reynato A. GamboaDean,

CEAFA

Final Exam - Engg 404 2022

Uploaded by

Copyright:

Available Formats

You might also like

Final Exam - Engg 404 2022

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Final Exam - Engg 404 2022

Uploaded by

Copyright:

Available Formats

Republic of the Philippines

BATANGAS STATE UNIVERSITY

College of Engineering, Architecture and Fine Arts

Second Semester, AY 2021-2022

1. Choose E if there are more than one correct option or

Leading Innovations, Transforming Lives

College of Engineering, Architecture and Fine Arts

1. Which of these cannot be considered a non-compensatory attribute when buying a phone? E.

3. If dominance check is used to conclude a decision from four alternatives,

4. A decision tree analysis

5. Decision reversal during sensitivity analysis

6. What can describe or exemplify a compensatory model?

Leading Innovations, Transforming Lives

10. If a decision is impossible to be made using one decision model, E.

Leading Innovations, Transforming Lives

College of Engineering, Architecture and Fine Arts

II. Recommend the Best Project (Mapped to ILO 4)

TP(A) = -20,000,000 + (200000-85000)(1-(1+0.037)-3) = -Php 19,679.038.71

Correct Answer: Project C ; higher B/C Ratio

3. Project A: Additive weight:0.75

Correct Answer: Project B ; higher additive weight

TC(A)=20000(0.4) + 30000(0.35) + 45000(0.25) =Php 29750.00

Correct Answer: Project A

Leading Innovations, Transforming Lives

LD(A)=1(0.43) + 0.5(0.31) + 0(0.26) = 0.585

Correct Answer: Leader A

III. Problem Solving (Mapped to ILO 5)

E(O)= O1(P1) + O2(P2) + O3(P3)

Leading Innovations, Transforming Lives

2. Find the value of A

3. Find the value of B.

4. Find the value of the present worth of C.

5. What is the decision value at D2?

6. Find the decision value at D1.

D3=2295; P3=0.29; D2=1440; P2=0.71

E(D12) > E(D11)

For 7-9, refer to the problem below:

7. Which of these conditions will indicate a decision reversal? (2 pts.)

PW= -150,000 + 19000(1-(1+0.1)-15) + 3,000(1+0.1)-15 = -P4766.313232

PW(A)= -150,000 + 19000(1-(1+0.152172)-15) + 3,000(1+0.152172)-15 = -P39699.12384

PW= -150,000 + 19000(1-(1+0.1)-15) + 3,000(1+0.1)-15 = -P4766.313232

Leading Innovations, Transforming Lives

College of Engineering, Architecture and Fine Arts

For 10-15, refer to the problem below. (3 pts. each)

Attributes Pfizer Moderna AstraZeneca Sinovac Novava

Leading Innovations, Transforming Lives

Attributes Pfizer Moderna AstraZeneca Sinovac Novavax

BEST VALUE, WORST VALUE

Under dominance check, none of the vaccines can be selected.

Leading Innovations, Transforming Lives

Through satisficing, the Pfizer Vaccine satisfy the parameters/conditions stated.

12. Using disjunctive resolution, how many vaccines shall be eliminated?

Through disjunctive resolution, none of the vaccines shall be eliminated.

Attributes Pfizer Moderna AstraZeneca Sinovac Novava

Leading Innovations, Transforming Lives

Attrib. Weights Pfizer Moderna AstraZeneca Sinovac Novavax

Delivery 0.0278 1 0.0278 1 0.0278 0 0 0 0 0.5 0.0139